ASX:RNO (Australia)  
Rhinomed Ltd logo

Rhinomed Ltd

A$ 0.11 (-4.55%) Dec 9
P/E:
At Loss
P/B:
5.83
Market Cap:
A$ 30.00M ($ 20.39M)
Enterprise V:
A$ 28.35M ($ 19.27M)
Volume:
17.00K
Avg Vol (2M):
79.42K
Also Trade In:
Volume:
17.00K
Market Cap A$:
30.00M
Market Cap $:
20.39M
PE Ratio:
At Loss
Avg Vol (2-Month):
79.42K
Enterprise Value A$:
28.35M
Enterprise Value $:
19.27M
PB Ratio:
5.83

Business Description

Description
Rhinomed Ltd is a medical technology company, with a patented nasal technology platform. It is engaged in the research, development and commercialization of consumer and medical devices including nasal, respiratory and nasal drug delivery technologies. It operates in one segment which is the identification, acquisition, and commercialisation of late-stage consumer therapeutic and medical delivery technologies.
Name Current Vs Industry Vs History
Cash-To-Debt 5.91
Equity-to-Asset 0.59
Debt-to-Equity 0.07
Debt-to-EBITDA -0.07
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -7.38
Distress
Grey
Safe
Beneish M-Score -2.1
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 7.57
9-Day RSI 21.95
14-Day RSI 28.69
6-1 Month Momentum % -31.25
12-1 Month Momentum % -60.45

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.73
Quick Ratio 1.34
Cash Ratio 0.62
Days Inventory 74.37
Days Sales Outstanding 51.09
Days Payable 193.47

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -26